Internal medicine, Women's Health Initiative, Placebo, Genetics and Genome-wide association study are her primary areas of study. Her work on Internal medicine deals in particular with Hazard ratio, Breast cancer, Risk factor, Vitamin D and neurology and Randomized controlled trial. Her Women's Health Initiative research includes themes of Incidence, Medroxyprogesterone acetate, Gynecology, Physical therapy and Hormone replacement therapy.
As a member of one scientific family, Rebecca D. Jackson mostly works in the field of Placebo, focusing on Surgery and, on occasion, Bone density, Postmenopausal women and Urology. Her Genome-wide association study study incorporates themes from Colorectal cancer, Case-control study, Genetic association and Genetic architecture. Rebecca D. Jackson has included themes like Black cohosh and Vaginal estrogen in her Transdermal estrogen study.
Her primary scientific interests are in Internal medicine, Genome-wide association study, Women's Health Initiative, Genetics and Endocrinology. Her work deals with themes such as Placebo and Surgery, which intersect with Internal medicine. Her Genome-wide association study research is multidisciplinary, incorporating perspectives in Genetic association, Locus and Bioinformatics.
Her Women's Health Initiative research is multidisciplinary, relying on both Physical therapy, Hip fracture, Osteoporosis, Gynecology and Hormone therapy. Many of her studies on Gynecology involve topics that are commonly interrelated, such as Breast cancer. Her research investigates the link between Endocrinology and topics such as Case-control study that cross with problems in Odds ratio.
Rebecca D. Jackson spends much of her time researching Genome-wide association study, Internal medicine, Disease, Osteoarthritis and Genetics. Her research investigates the connection with Genome-wide association study and areas like Genetic association which intersect with concerns in Precision medicine, Odds ratio, Omics and Data collection. The various areas that Rebecca D. Jackson examines in her Internal medicine study include Endocrinology and Oncology.
Her study focuses on the intersection of Genetics and fields such as Adiponectin with connections in the field of Human genetics. Her research in Women's Health Initiative focuses on subjects like Hip fracture, which are connected to Bone Mineral Density Test, Incidence, Postmenopausal women, Ambulatory and Metabolic equivalent. As a part of the same scientific family, Rebecca D. Jackson mostly works in the field of Randomized controlled trial, focusing on Urology and, on occasion, Breast cancer.
Her primary areas of investigation include Genome-wide association study, Genetics, Physical therapy, Genetic association and Expression quantitative trait loci. Her Genome-wide association study study combines topics from a wide range of disciplines, such as SNP, Genetic architecture and Genomics. Within one scientific family, she focuses on topics pertaining to Meta-analysis under Genetics, and may sometimes address concerns connected to Valgus, Imputation and Genetic epidemiology.
Her work carried out in the field of Physical therapy brings together such families of science as Osteoarthritis, Body mass index, Bone Mineral Density Test, Women's Health Initiative and Cohort. As a part of the same scientific study, Rebecca D. Jackson usually deals with the Women's Health Initiative, concentrating on Metabolic equivalent and frequently concerns with Internal medicine. In Genetic association, Rebecca D. Jackson works on issues like Allele, which are connected to Oncology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial
Jacques E. Rossouw;Garnet L. Anderson;Ross L. Prentice;Andrea Z. LaCroix.
Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial
Garnet L. Anderson;Marian C. Limacher;Annlouise R. Assaf;Tamsen Bassford.
Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.
Sally A. Shumaker;Claudine Legault;Stephen R. Rapp;Leon Thal.
Calcium plus vitamin D supplementation and the risk of fractures.
Rebecca D. Jackson;Andrea Z. LaCroix;Margery Gass;Robert B. Wallace.
The New England Journal of Medicine (2006)
Intermittent cyclical etidronate treatment of postmenopausal osteoporosis.
N B Watts;S T Harris;H K Genant;R D Wasnich.
The New England Journal of Medicine (1990)
Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial.
Jane A. Cauley;John Robbins;Zhao Chen;Steven R. Cummings.
Calcium plus Vitamin D Supplementation and the Risk of Colorectal Cancer
Jean Wactawski-Wende;Jane Morley Kotchen;Garnet L. Anderson;Annlouise R. Assaf;Annlouise R. Assaf.
The New England Journal of Medicine (2006)
Menopausal Hormone Therapy and Health Outcomes During the Intervention and Extended Poststopping Phases of the Women’s Health Initiative Randomized Trials
Jo Ann E. Manson;Rowan T. Chlebowski;Marcia L. Stefanick;Aaron K. Aragaki.
Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture
Karol Estrada;Unnur Styrkarsdottir;Evangelos Evangelou;Yi-Hsiang Hsu.
Nature Genetics (2012)
A Pooled Analysis of Vitamin D Dose Requirements for Fracture Prevention
Heike A. Bischoff-Ferrari;Walter C. Willett;Endel J. Orav;Paul Lips.
The New England Journal of Medicine (2012)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: